# Task X21: Preparedness for Testing NIAID Priority Vaccines in General Safety and Toxicology Studies

> **NIH NIH N01** · BATTELLE CENTERS/PUB HLTH RES & EVALUATN · 2020 · $814,926

## Abstract

The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through manufacture of Phase I/II material, including assay development; immunogenicity and efficacy testing; clinical and nonclinical sample testing; and safety and toxicity testing.  These services will facilitate the development and introduction of new vaccines and biologics against potential agents of bioterrorism, drug-resistant pathogens, and emerging and re-emerging infectious diseases.

## Key facts

- **NIH application ID:** 10251825
- **Project number:** 272201200003I-P00005-27200021-1
- **Recipient organization:** BATTELLE CENTERS/PUB HLTH RES & EVALUATN
- **Principal Investigator:** RANDI HORNBACK
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $814,926
- **Award type:** —
- **Project period:** 2017-07-01 → 2022-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10251825

## Citation

> US National Institutes of Health, RePORTER application 10251825, Task X21: Preparedness for Testing NIAID Priority Vaccines in General Safety and Toxicology Studies (272201200003I-P00005-27200021-1). Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/grant/nih/10251825. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*